Karim R. Saab

934 total citations
9 papers, 478 citations indexed

About

Karim R. Saab is a scholar working on Oncology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Karim R. Saab has authored 9 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 2 papers in Immunology and Allergy. Recurrent topics in Karim R. Saab's work include Cell Adhesion Molecules Research (2 papers), Melanoma and MAPK Pathways (2 papers) and Cancer Cells and Metastasis (2 papers). Karim R. Saab is often cited by papers focused on Cell Adhesion Molecules Research (2 papers), Melanoma and MAPK Pathways (2 papers) and Cancer Cells and Metastasis (2 papers). Karim R. Saab collaborates with scholars based in United States, Australia and Germany. Karim R. Saab's co-authors include Gëorge F. Murphy, Markus H. Frank, Brian J. Wilson, Tobias Schatton, Martin Gasser, Natasha Y. Frank, Qian Zhan, Jie Ma, Jie Ma and Ana Maria Waaga-Gasser and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Karim R. Saab

9 papers receiving 475 citations

Peers

Countries citing papers authored by Karim R. Saab

Since Specialization

Citations

This map shows the geographic impact of Karim R. Saab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim R. Saab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim R. Saab more than expected).

Fields of papers citing papers by Karim R. Saab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karim R. Saab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim R. Saab. The network helps show where Karim R. Saab may publish in the future.

Co-authorship network of co-authors of Karim R. Saab

This figure shows the co-authorship network connecting the top 25 collaborators of Karim R. Saab. A scholar is included among the top collaborators of Karim R. Saab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karim R. Saab. Karim R. Saab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Personalized outcomes in neuropathic pain: a clinical relevance and assay sensitivity analysis from a randomized controlled trial 2024 ·Pain Medicine ·Karim R. Saab, (unknown), (unknown), Brian L. Burnette, (unknown), (unknown), Gary R. Morrow, Karen M. Mustian, Michael B. Sohn, Robert R. Edwards, Roy Freeman, Dale J. Langford, Michael P. McDermott, Jennifer S. Gewandter	1
2	Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1‐based therapy 2018 ·Cancer ·Karim R. Saab, Meghan J. Mooradian, Daniel Wang, (unknown), (unknown), (unknown), (unknown), Alexander M. Menzies, Douglas B. Johnson, Ryan J. Sullivan, Alexander N. Shoushtari	40
3	Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who have received PD-1 based therapy. 2018 ·Journal of Clinical Oncology ·Karim R. Saab, Meghan J. Mooradian, (unknown), (unknown), (unknown), (unknown), (unknown), Alexander M. Menzies, Douglas B. Johnson, Ryan J. Sullivan, Alexander N. Shoushtari	1
4	Thrombotic Microangiopathy in the Setting of HIV Infection: A Case Report and Review of the Differential Diagnosis and Therapy 2016 ·AIDS Patient Care and STDs ·Karim R. Saab, Sonia Elhadad, Dennis C. Copertino, Jeffrey Laurence	12
5	ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth 2016 ·Journal of Investigative Dermatology ·Sonja Kleffel, Nayoung Lee, Cecilia Lezcano, Brian J. Wilson, (unknown), Karim R. Saab, Hansgeorg Mueller, Qian Zhan, Christian Posch, Christopher P. Elco, Andrew DoRosario, (unknown), Manisha Thakuria, Yaoyu E. Wang, Linda C. Wang, Gëorge F. Murphy, Markus H. Frank, Tobias Schatton	19
6	ABCB5 Maintains Melanoma-Initiating Cells through a Proinflammatory Cytokine Signaling Circuit 2014 ·Cancer Research ·Brian J. Wilson, Karim R. Saab, Jie Ma, Tobias Schatton, (unknown), Qian Zhan, Gëorge F. Murphy, Martin Gasser, Ana Maria Waaga-Gasser, Natasha Y. Frank, Markus H. Frank	116
7	New Insights on the Risk for Cardiovascular Disease in African Americans 2014 ·Journal of the American Society of Nephrology ·Karim R. Saab, Jessica Kendrick, Joseph Yracheta, Miguel A. Lanaspa, (unknown), Richard J. Johnson	43
8	ABCB5 Identifies a Therapy-Refractory Tumor Cell Population in Colorectal Cancer Patients 2011 ·Cancer Research ·Brian J. Wilson, Tobias Schatton, Qian Zhan, Martin Gasser, Jie Ma, Karim R. Saab, (unknown), (unknown), Jason S. Gold, Qin Huang, Gëorge F. Murphy, Markus H. Frank, Natasha Y. Frank	113
9	VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth 2011 ·Cancer Research ·Natasha Y. Frank, Tobias Schatton, Soo‐Jeong Kim, Qian Zhan, Brian J. Wilson, Jie Ma, Karim R. Saab, (unknown), Hans R. Widlund, Martin Gasser, (unknown), Thomas S. Kupper, Gëorge F. Murphy, Markus H. Frank	133

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact